Zdrowie i gospodarka · 22/08/2018
FDA Clears DITROPAN XL for Approval After Safety Review
The FDA has determined that DITROPAN XL (oxybutynin chloride) Extended Release Tablets, 15 mg, were not withdrawn from sale due to safety concerns, paving the way for potential approval of abbreviated new drug applications.